Product Introduction:The Pelvic Inflammatory Disease (PID) Treatment Device integrates electrotherapy, heat therapy, vibration massage, and other physical therapies to comprehensively and three-dimensionally treat pelvic inflammatory disease from different angles. The full menu selection is intuit
Product Introduction: The Pelvic Inflammatory Disease (PID) Treatment Device integrates electrotherapy, heat therapy, vibration massage, and other physical therapies to comprehensively and three-dimensionally treat pelvic inflammatory disease from different angles. The full menu selection is intuitive with simple operation. The upright trolley design is convenient for clinical use. It is a multi-functional device, saving costs and space. It has passed the YY0505-2012 electromagnetic compatibility test, with highly integrated circuits for high reliability. The device features anti-electric protection design to ensure patient comfort during startup, shutdown, sudden power loss, and button operations.
Product Configuration: Main unit, probe, abdominal electrode, software.
Scope of Application: Suitable for the auxiliary treatment of chronic pelvic inflammatory disease.
Technical Parameters:
Pulse Frequency: 1000Hz ±10% error;
Pulse Width: 0.5ms ±30% error;
Single Pulse Energy: Maximum output energy not exceeding 300mJ;
Output intensity of the treatment device is adjustable from level 1 to 17 continuously.
Output Amplitude of the Treatment Device: The maximum output amplitude of the treatment device is not greater than 40V; The effective value of the treatment device output is not greater than 10V.
The temperature of the intra-cavity probe can be set to 6 levels; Vibration speed is adjustable from 0 to 2 levels, with a vibration speed of 0-2.5mm/s;
Timer: 05-60min in 5min increments, ±1min error; Countdown display of remaining time after startup, with a buzzer sounding and the device returning to the initial settings after the timer ends.
Output Current: Maximum output current: not greater than 80mA; Maximum open-circuit voltage: <100V;
Output Current Stability: The rate of change of current output under different loads should not exceed 10%.
If the abdominal electrode and intra-cavity probe of the treatment device are installed incorrectly or loosely connected, the device will not output and will have an audible prompt.
The temperature of the abdominal electrode should meet the following requirements: When the treatment device reaches a steady state, the temperature in the effective heating area should not be lower than 37℃; The steady-state temperature of the abdominal electrode is 45℃, with an error not exceeding ±3℃; The highest temperature of the abdominal electrode should be less than 60℃; Temperature uniformity: The difference between the average surface temperature of the effective heating area and each test point should not exceed ±2.5℃; Temperature stability: After the treatment device reaches a steady state, the temperature fluctuation should not exceed 2℃.
Modulation Frequency Range: The modulation frequency of low-frequency modulation intermediate frequency electrotherapy devices should be in the range of 0-150Hz, with a modulation depth of 100%.
The treatment device has two independent over-temperature protection devices. When the temperature of the abdominal electrode exceeds the set working temperature, the first protection device should act, cutting off the output. The action temperature of the protection device should not exceed the set working temperature +3℃. If the treatment device adopts a thermostat for temperature control, the output may not be cut off when the temperature control device is activated.
In a single fault state (such as the failure of the first protection device), if the highest temperature in the effective heating area continues to rise to 60℃, the second protection device should act, cutting off the output and not allowing automatic recovery.